Merck’s $4.85 Billion Vioxx Settlement Could Set Industry Standard To Resolve Litigation
This article was originally published in The Pink Sheet Daily
Executive Summary
Agreement to resolve the bulk of Vioxx litigation guards against Merck's future liability, an analyst tells "The Pink Sheet" DAILY.
You may also be interested in...
Pfizer Forks Over $894 Million To Settle Celebrex/Bextra Litigation
Agreement represents less than half of the firm’s annual Celebrex sales.
Pfizer Forks Over $894 Million To Settle Celebrex/Bextra Litigation
Agreement represents less than half of the firm’s annual Celebrex sales.
Merck Accepts DTC Limits In Deal With States
Firm to pay $58 million to settle claims its consumer ads deceived the public on Vioxx safety.